Home/Filings/4/0001193125-26-018320
4//SEC Filing

Khara Rahul 4

Accession 0001193125-26-018320

CIK 0001816736other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 6:55 PM ET

Size

8.5 KB

Accession

0001193125-26-018320

Research Summary

AI-generated summary of this filing

Updated

Disc Medicine (IRON) CLO Rahul Khara Exercises Options, Sells Shares

What Happened

  • Rahul Khara, Chief Legal Officer of Disc Medicine (IRON), exercised stock options and sold shares on January 20, 2026. She exercised 1,000 option shares at $13.50 per share (cost $13,500) and sold 1,000 shares in an open-market transaction at $69.74 per share (proceeds $69,740). The filing also reports a separate derivative disposition of 1,000 shares at $0 (reported as an M-coded derivative transaction).

Key Details

  • Transaction date: 2026-01-20.
  • Exercise: 1,000 shares exercised at $13.50 (total cost $13,500).
  • Open-market sale: 1,000 shares sold at $69.74 (total proceeds $69,740).
  • Additional derivative disposition: 1,000 shares at $0 reported (details not specified in the summary).
  • Plan/footnote: Transactions were effected pursuant to a Rule 10b5-1 trading plan adopted Sept 23, 2025 (F1).
  • Vesting note: Underlying option vests in 48 equal monthly installments following Dec 29, 2022 (F2).
  • Shares owned after the reported transactions: not specified in the provided excerpt.
  • Filing timeliness: report filed Jan 21, 2026 for transactions on Jan 20, 2026 (appears timely).

Context

  • The insider exercised options and sold shares the same day. Same-day sales following an exercise are commonly used to cover the exercise cost and taxes (a cashless-style practice), but the filing does not state the specific purpose. The 10b5-1 plan note indicates the sale was executed under a pre-established trading plan.

Insider Transaction Report

Form 4
Period: 2026-01-20
Khara Rahul
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-20$13.50/sh+1,000$13,50038,793 total
  • Sale

    Common Stock

    [F1]
    2026-01-20$69.74/sh1,000$69,74037,793 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F2]
    2026-01-201,00021,270 total
    Exercise: $13.50Exp: 2032-12-28Common Stock (1,000 underlying)
Footnotes (2)
  • [F1]The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025.
  • [F2]The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date.
Signature
By: /s/ Rahul Khara|2026-01-21

Documents

1 file

Issuer

Disc Medicine, Inc.

CIK 0001816736

Entity typeother

Related Parties

1
  • filerCIK 0001951850

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 6:55 PM ET
Size
8.5 KB